{"id":8566,"date":"2026-08-20T13:20:08","date_gmt":"2026-08-20T07:50:08","guid":{"rendered":"https:\/\/lakshmishree.com\/news\/?p=8566"},"modified":"2026-08-21T12:55:27","modified_gmt":"2026-08-21T07:25:27","slug":"details-of-symbiotec-pharmalab-limited","status":"publish","type":"post","link":"https:\/\/lakshmishree.com\/news\/details-of-symbiotec-pharmalab-limited\/","title":{"rendered":"Details of Symbiotec Pharmalab Limited IPO : Lot Size, Check Issue Date, Price"},"content":{"rendered":"\n

Symbiotec Pharmalab<\/strong> Limited IPO Price: <\/strong>\u20b9938 to \u20b9988 per share<\/p>\n\n\n\n

IPO Dates:<\/strong> 24 Aug to 27 Aug, 2026<\/p>\n\n\n\n

\n
\n
\n
\n
\"\"<\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n

Company Overview<\/strong><\/h2>\n\n\n\n

Incorporated in 2002, Symbiotec Pharmalab Ltd. is a pharmaceutical and biotechnology company engaged in the development and manufacturing of active pharmaceutical ingredients (APIs), nutritional ingredients, and specialty products.<\/p>\n\n\n\n

The company serves domestic and international markets across regulated and emerging regions.<\/p>\n<\/div>\n<\/div>\n\n\n\n

Business Operations<\/h2>\n\n\n\n

With over 30 years of industry experience, Symbiotec Pharmalab has evolved from a lab-scale steroidal hormone API manufacturer in 1995 into an industrial-scale, backward-integrated manufacturing platform.<\/p>\n\n\n\n

The company focuses on research-driven manufacturing, quality compliance, and sustainable production processes.<\/p>\n\n\n\n

Product Focus<\/h2>\n\n\n\n

The company manufactures active pharmaceutical ingredients (APIs), nutritional ingredients, and specialty products.<\/p>\n\n\n\n

It supports the pharmaceutical, nutraceutical, and wellness industries by providing high-quality ingredients aligned with global standards.<\/p>\n\n\n\n

Manufacturing Facilities<\/h2>\n\n\n\n

As of June 30, 2025, the company operated two industrial-scale API manufacturing facilities.<\/p>\n\n\n\n

The facilities have a maximum chemical synthesis capacity of 584.67 metric tonnes (MT) and fermentation capacity of 300 kilolitres.<\/p>\n\n\n\n

Regulatory Approvals<\/h2>\n\n\n\n

The company has approvals from the United States Food and Drug Administration (US FDA), European Union Good Manufacturing Practices (EU-GMP), Ministry of Food and Drug Safety, Korea, and other global regulatory organisations.<\/p>\n\n\n\n

Market Position<\/h2>\n\n\n\n

The company has established global leadership in corticosteroid and steroidal hormone APIs.<\/p>\n\n\n\n

Customer Base<\/h2>\n\n\n\n

Symbiotec Pharmalab has long-standing relationships with domestic and international customers.<\/p>\n\n\n\n

Research & Development<\/h2>\n\n\n\n

The company continuously invests in research and development, supported by strong technological capabilities among Indian industry peers.<\/p>\n\n\n\n

The company also leverages its scientific expertise and existing capabilities to expand its total addressable market and develop intellectual property-driven offerings.<\/p>\n\n\n\n

Competitive Strengths<\/h2>\n\n\n\n